Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirect Line Regulatory News (DLG)

Share Price Information for Direct Line (DLG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 192.80
Bid: 193.40
Ask: 193.70
Change: -0.60 (-0.31%)
Spread: 0.30 (0.155%)
Open: 193.30
High: 194.30
Low: 190.20
Prev. Close: 193.40
DLG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)-Direct Line Insurance Group plc

12 Mar 2024 11:47

RNS Number : 5422G
JPMorgan Securities Plc
12 March 2024
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

J.P. Morgan Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Direct Line Insurance Group plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Financial Adviser to Direct Line Insurance Group plc

(d) Date dealing undertaken:

11 March 2024

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes, Ageas SA/NV

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary 10 10/11p

Purchase

 

Sale

822,945

 

 712,313

2.2510 GBP

 

 2.2380 GBP

2.2050 GBP

 

 2.2050 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Ordinary 10 10/11p

Equity Swap

Decrease Long

 

 

Decrease Short

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Increase Long

 

 

 

 

 

 

Increase Short

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8,260

 2,688

 

 2,333

 10,000

 474

 2

 1,512

 10,634

 3,621

 6,103

 119,435

 13,949

 7,566

 10,817

 27,695

 1,352

 1,114

 900

 21,029

 75,473

 264

 61,962

 982

 3,228

 1,561

 3,404

 11,126

 52

 

 54,267

 22,422

 3,071

 28

 2

 2,532

 

 8,716

 9,215

 131,500

 123,667

 21,576

 2,050

 2,368

 19,200

 5,606

 8,359

 16,260

 100,000

 7,908

 19,354

 10,527

 31,452

 67,363

 2,027

 885

2.2193 GBP

2.2253 GBP

 

2.2059 GBP

2.2068 GBP

2.2085 GBP

2.2099 GBP

2.2117 GBP

2.2134 GBP

2.2135 GBP

2.2147 GBP

2.2157 GBP

2.2160 GBP

2.2163 GBP

2.2192 GBP

2.2199 GBP

2.2205 GBP

2.2220 GBP

2.2223 GBP

2.2226 GBP

2.2227 GBP

2.2233 GBP

2.2243 GBP

2.2249 GBP

2.2250 GBP

2.2259 GBP

2.2295 GBP

2.2374 GBP

2.2700 GBP

 

2.2167 GBP

2.2170 GBP

2.2199 GBP

2.2227 GBP

2.2228 GBP

2.2246 GBP

 

2.2100 GBP

2.2110 GBP

2.2111 GBP

2.2148 GBP

2.2160 GBP

2.2167 GBP

2.2169 GBP

2.2183 GBP

2.2188 GBP

2.2189 GBP

2.2202 GBP

2.2211 GBP

2.2228 GBP

2.2243 GBP

2.2248 GBP

2.2250 GBP

2.2251 GBP

2.2310 GBP

2.2371 GBP

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

12 March 2024

Contact name:

Natasha Mondon

Telephone number:

01202 325175

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERFLLFFZXLZBBQ
Date   Source Headline
31st Aug 20236:00 pmRNSDirectorate Change
30th Aug 20234:00 pmRNSDirector/PDMR Shareholding
30th Aug 20237:00 amRNSAppointment of CEO
28th Jul 20234:00 pmRNSDirector/PDMR Shareholding
29th Jun 20237:00 amRNSResponse to press coverage
28th Jun 20232:00 pmRNSDirector/PDMR Shareholding
1st Jun 20235:00 pmRNSNotice of Results
31st May 20233:00 pmRNSDirector/PDMR Shareholding
30th May 20236:30 pmRNSDirector/PDMR Shareholding
30th May 20235:30 pmRNSDirector/PDMR Shareholding
12th May 20233:30 pmRNSDirector/PDMR Shareholding
9th May 20233:00 pmRNSResult of AGM
9th May 20237:00 amRNSTrading Update for Q1 2023
28th Apr 20233:00 pmRNSDirector/PDMR Shareholding
25th Apr 20235:00 pmRNSHolding(s) in Company
14th Apr 20234:00 pmRNSHolding(s) in Company
3rd Apr 20234:15 pmRNSDirector/PDMR Shareholding
3rd Apr 202312:00 pmRNSNotice of 2023 AGM
31st Mar 20233:00 pmRNSHolding(s) in Company
31st Mar 20232:30 pmRNS2022 Solvency and Financial Condition Report
30th Mar 20233:00 pmRNSAppointment to Board Committees
28th Mar 20233:30 pmRNSDirector/PDMR Shareholding
28th Mar 20233:30 pmRNSDirector/PDMR Shareholding
24th Mar 20239:30 amRNS2022 Annual Report and Accounts
20th Mar 20234:00 pmRNSHolding(s) in Company
14th Mar 20236:30 pmRNSHolding(s) in Company
13th Mar 20237:00 amRNSPreliminary Results year ended 31 December 2022
10th Mar 202310:15 amRNSDirector Declaration
1st Mar 20235:00 pmRNSHolding(s) in Company
28th Feb 20234:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20236:15 pmRNSHolding(s) in Company
17th Feb 20237:00 amRNSDirectorate Change
15th Feb 20237:00 amRNSNotice of 2022 preliminary results
30th Jan 20233:00 pmRNSDirector/PDMR Shareholding
27th Jan 20237:00 amRNSDirectorate Change
26th Jan 20237:00 amRNSDirect Line Group executes strategic reinsurance
16th Jan 20236:00 pmRNSHolding(s) in Company
12th Jan 20233:00 pmRNSHolding(s) in Company
11th Jan 20237:00 amRNSTrading Update
29th Dec 202212:00 pmRNSDirector/PDMR Shareholding
13th Dec 20224:00 pmRNSHolding(s) in Company
12th Dec 20227:00 amRNSIFRS 17 update
29th Nov 20224:30 pmRNSDirector/PDMR Shareholding
29th Nov 20224:30 pmRNSDirector/PDMR Shareholding
18th Nov 20224:00 pmRNSHolding(s) in Company
11th Nov 20223:00 pmRNSHolding(s) in Company
8th Nov 20227:00 amRNSTrading Update for Q3 2022
28th Oct 20225:30 pmRNSDirector/PDMR Shareholding
10th Oct 202211:30 amRNSChange of Auditor
28th Sep 20226:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.